| type : |
Artikel |
| internetlink : |
https://doi.org/10.1002/jppr.1631 |
|
| onderzoeksgroepen : |
Adelaïde - Royal Adelaide Hospital, Department of Pharmacy |
| Auteur : |
Song Y, Lwin E, Ellis D, Turner S, Williams D, Garg S. |
| titel : |
Stability evaluation of an extemporaneously compounded carbimazole oral suspension. |
| Nummer : |
J Pharm Pract and Res 2020 |
|
| Niveau van bewijs : |
|
| fysische stabiliteit : |
|
| chemische stabiliteit : |
|
| andere methoden : |
|
| Reacties : |
|
Stoffenlijst
 Carbimazole
|
 |
 |
 |
 |
600 mg
Neomercazole® |
| OraPlus® / OraSweet SF® (1:1) |
>> 300 mL |
|
25°C |
 |
| 2 |
 |
|
|
|
|
|
600 mg
Neomercazole® |
| OraPlus® / OraSweet SF® (1:1) |
>> 300 mL |
|
4°C |
|
| 14 |
|
|
|
|
|
